Positive attitude is best prevention against heart disease

November 12, 2001

A positive outlook may offer the strongest known protection against heart disease in adults at risk, according to a Johns Hopkins study. The report, which looked at nearly 600 adults with a family history of heart disease, will be presented Nov. 12 at the American Heart Association's annual Scientific Sessions in Anaheim, Calif.

Study participants with a good attitude were only half as likely as their less optimistic counterparts to experience a heart "event" - such as sudden death, heart attack or unstable chest pain that required surgery - during an average seven-and-a-half-year period. This result was seen among all participants regardless of age, race or sex. Researchers observed the power of positive thinking even after adjusting for traditional risk factors for heart disease, including cholesterol, weight and cigarette smoking.

"It's possible that the people with positive attitude produce lower levels of stress hormones, which helps protect them from disease," says Diane M. Becker, Sc.D., M.P.H., senior author of the study and director of Hopkins' Center for Health Promotion. "In future studies, we'd like to examine whether adding pleasurable activities to the lives of this population affects heart disease risk."

Researchers studied 586 adults ages 30 to 59 with no symptoms of heart disease but whose brothers and sisters had been diagnosed with early heart disease. All subjects underwent a standardized personality survey as well as tests for high blood pressure, blood sugar, body fat measurements, blood fat levels, smoking and other risk factors, diabetes and lifestyle information. Participants were then followed for five to 12 years with regular stress tests and questionnaires.

At the study's start, the participants had an average age of 45. Fifty-one percent were male and 17 percent were African American. During the follow-up period, 70 participants (11.9 percent) had heart events. Education level, diabetes and smoking status were not found to be strong predictors of heart disease.
-end-
The study's co-authors were Lisa R. Yanek, Taryn F. Moy and Lewis C. Becker.

Abstract #103966: "General Well-being is Strongly Protective Against Future Coronary Heart Disease Events in an Apparently Healthy High-risk Population."

Links: Johns Hopkins - Division of Cardiology http://www.cardiology.hopkinsmedicine.org/

American Heart Association Scientific Sessions http://www.scientificsessions.org/

Media contact: Karen Blum(410)955-1534
Email: kblum@jhmi.edu

Johns Hopkins Medical Institutions' news releases are available on an EMBARGOED basis on EurekAlert at http://www.eurekalert.org, and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkins@jhmi.edu.

On a POST-EMBARGOED basis find them at http://www.hopkinsmedicine.org

Johns Hopkins Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.